The BioLung is an artificial lung that can replace the gas exchange function of a person’s native lungs during recovery from injury or illness, or until donor lungs are available for transplantation.
MC3 engineers designed and patented the BioLung. Further development was completed through laboratory testing in conjunction with academic collaborators and with support from NIH.
The BioLung is not yet ready for human use.
MC3 has partnered with Novalung, GmbH, to advance artificial lung technologies. See Novalung.com for information about clinical applications of artificial lungs.